Translational Modeling Predicts Efficacious Therapeutic Dosing Range of Teclistamab for Multiple Myeloma (June, 10.1007/s11523-022-00893-y, 2022)

被引:1
作者
Girgis, Suzette [1 ]
Lin, Shun Xin Wang [2 ]
Pillarisetti, Kodandaram [2 ]
Banerjee, Arnob [2 ]
Stephenson, Tara [2 ]
Ma, Xuewen [2 ]
Shetty, Shoba [2 ]
Yang, Tong-Yuan [2 ]
Hilder, Brandi W. [2 ]
Jiao, Qun [2 ]
Hanna, Brett [2 ]
Adams, Homer C., III [2 ]
Sun, Yu-Nien [2 ]
Sharma, Amarnath [3 ]
Smit, Jennifer [2 ]
Infante, Jeffrey R. [1 ]
Goldberg, Jenna D.
Elsayed, Yusri [2 ]
机构
[1] Janssen Res & Dev, 920 Route 202, Raritan, NJ 08869 USA
[2] Janssen Res & Dev, Spring House, PA USA
[3] Janssen Res & Dev, Tokyo, Japan
关键词
D O I
10.1007/s11523-022-00904-y
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:609 / 609
页数:1
相关论文
共 1 条
  • [1] Translational Modeling Predicts Efficacious Therapeutic Dosing Range of Teclistamab for Multiple Myeloma
    Girgis, Suzette
    Lin, Shun Xin Wang
    Pillarisetti, Kodandaram
    Banerjee, Arnob
    Stephenson, Tara
    Ma, Xuewen
    Shetty, Shoba
    Yang, Tong-Yuan
    Hilder, Brandi W.
    Jiao, Qun
    Hanna, Brett
    Adams, Homer
    Sun, Yu-Nien
    Sharma, Amarnath
    Smit, Jennifer
    Infante, Jeffrey R.
    Goldberg, Jenna D.
    Elsayed, Yusri
    [J]. TARGETED ONCOLOGY, 2022, 17 (04) : 433 - 439